CIK: 0001768824 · Show all filings
Period: Q2 2024 (← Previous) (Next →)
Filing Date: Aug 7, 2024
Total Value ($000): $40 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| BHP | BHP GROUP LIMITED | 123,960 | $7 | 17.7% | $0.06 | — | COM | 088606108 |
| RIO | RIO TINTO PLC | 103,100 | $7 | 17.0% | $0.06 | — | COM | 767204100 |
| EQT | EQT CORP | 150,800 | $6 | 14.0% | $38.26 | +0.1% | COM | 26884L109 |
| META | META PLATFORMS INC | 10,589 | $5 | 13.4% | $116.61 | +314.5% | COM | 30303M102 |
| VALE | VALE SA | 404,000 | $5 | 11.3% | $0.01 | — | COM | 91912E105 |
| XOMA | XOMA | 120,365 | $3 | 7.1% | $18.17 | +37.7% | COM | 98419J206 |
| RRC | RANGE RESOURCES CORP | 47,923 | $2 | 4.0% | $27.38 | +31.3% | COM | 75281A109 |
| XENE | XENON PHARMS | 32,956 | $1 | 3.2% | $36.42 | +9.8% | COM | 98420N105 |
| NUE | NUCOR CORP | 8,000 | $1 | 3.2% | $168.96 | 0.0% | COM | 670346105 |
| OABI | OMNIAB | 250,185 | $1 | 2.3% | $5.33 | -14.5% | COM | 68218J103 |
| OVID | OVID THERAPEUTICS INC | 1,125,296 | $1 | 2.2% | $1.70 | +63.3% | COM | 690469101 |
| HOV | HOVNANIAN | 3,872 | $1 | 1.4% | $42.38 | +254.8% | COM | 442487401 |
| WY | WEYERHAEUSER CO | 15,000 | $0 | 1.1% | $29.42 | 0.0% | COM | 962166104 |
| NBIS | YANDEX NV-A COM STK | 17,811 | $0 | 0.7% | — | — | COM | N97284108 |
| REGN | REGENERON PHARMACEUTICALS INC | 250 | $0 | 0.7% | $781.58 | +23.3% | COM | 75886F107 |
| EWS | ISHARES MSCI SINGAPORE | 13,600 | $0 | 0.7% | $0.02 | — | COM | 46434G780 |
| AEI | ALSET EHOME INT. INC. | 11,140 | $0 | 0.0% | $0.80 | 0.0% | COM | 02115D208 |
| — | ENZO BIOCHEM INC | 13,616 | $0 | 0.0% | $0.00 | — | COM | 294100102 |
| RVP | RETRACTABLE TECHNOLOGIES INC | 12,152 | $0 | 0.0% | $1.22 | -11.4% | COM | 76129W105 |